• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术与药物治疗对格雷夫斯病心血管表现的影响。

Impact of surgery versus medical management on cardiovascular manifestations in Graves disease.

机构信息

Department of Surgery, Tulane University School of Medicine, New Orleans, LA.

Department of Surgery, Tulane University School of Medicine, New Orleans, LA.

出版信息

Surgery. 2021 Jan;169(1):82-86. doi: 10.1016/j.surg.2020.03.023. Epub 2020 May 10.

DOI:10.1016/j.surg.2020.03.023
PMID:32402541
Abstract

BACKGROUND

Graves disease is well known to have multiple adverse effects on the cardiovascular system. We compared the cardiovascular outcomes after surgical intervention versus medical treatment in patients with Graves disease.

METHODS

We performed a retrospective study of all Graves disease patients with a cardiovascular comorbidity who underwent either surgical or medical management (N = 151). Perioperative biochemical and cardiovascular outcomes from the surgical versus the medical groups were analyzed.

RESULTS

Of 151 patients, 69 (45.6%) patients underwent total thyroidectomy and 82 (54.3%) patients received medical treatment. Hypertension resolved in 44.7% of the patients from the surgical group vs 18% in the medical group (P = .03). Tachyarrhythmias, including atrial fibrillation and tachycardia, improved in 85.9% of patients in the surgical group vs 66% in the medical group (P = .01). All cardiovascular manifestations examined, hypertension, tachyarrhythmias, and heart failure, improved in 69% of patients in the surgical group and 42.6% of patients in the medical group during the follow-up period (P < .01).

CONCLUSION

Surgical treatment offers a significant and rapid clinical improvement of cardiovascular manifestations in Graves disease patients, such as hypertension, tachyarrhythmias, and heart failure. Surgery should be considered and recommended in Graves disease patients with known cardiovascular manifestations.

摘要

背景

众所周知,格雷夫斯病(Graves disease)对心血管系统有多种不良影响。我们比较了格雷夫斯病患者手术干预与药物治疗后的心血管结局。

方法

我们对所有患有心血管合并症并接受手术或药物治疗的格雷夫斯病患者进行了回顾性研究(N=151)。分析了手术组与药物组患者的围手术期生化和心血管结局。

结果

在 151 例患者中,69 例(45.6%)患者行甲状腺全切除术,82 例(54.3%)患者接受药物治疗。手术组中 44.7%的高血压患者得到缓解,而药物组中仅 18%的患者得到缓解(P=0.03)。手术组中 85.9%的心动过速患者(包括心房颤动和心动过速)得到改善,而药物组中仅 66%的患者得到改善(P=0.01)。在随访期间,手术组中 69%的患者和药物组中 42.6%的患者的所有心血管表现(高血压、心动过速和心力衰竭)均得到改善(P<0.01)。

结论

手术治疗可显著快速改善格雷夫斯病患者的心血管表现,如高血压、心动过速和心力衰竭。对于已知有心血管表现的格雷夫斯病患者,应考虑并推荐手术治疗。

相似文献

1
Impact of surgery versus medical management on cardiovascular manifestations in Graves disease.手术与药物治疗对格雷夫斯病心血管表现的影响。
Surgery. 2021 Jan;169(1):82-86. doi: 10.1016/j.surg.2020.03.023. Epub 2020 May 10.
2
Impact of thyroidectomy on cardiac manifestations of Graves' disease.甲状腺切除术对格雷夫斯病心脏表现的影响。
Laryngoscope. 2016 May;126(5):1256-9. doi: 10.1002/lary.25687. Epub 2016 Mar 1.
3
Cardiovascular Outcomes of Thyroidectomy or Radioactive Iodine Ablation for Graves' Disease.甲状腺切除术或放射性碘消融治疗格雷夫斯病的心血管结局。
J Surg Res. 2020 Dec;256:486-491. doi: 10.1016/j.jss.2020.07.020. Epub 2020 Aug 13.
4
Epidemiology, management and outcomes of Graves' disease-real life data.格雷夫斯病的流行病学、管理及转归——真实世界数据
Endocrine. 2017 Jun;56(3):568-578. doi: 10.1007/s12020-017-1306-5. Epub 2017 May 6.
5
Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.格雷夫斯病中的甲状腺结节:分类、特征及治疗反应
Thyroid. 1998 Jul;8(7):571-6. doi: 10.1089/thy.1998.8.571.
6
Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.格雷夫斯病中的甲状腺结节:分类、特征及治疗反应
Thyroid. 1998 Aug;8(8):647-52. doi: 10.1089/thy.1998.8.647.
7
The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.格雷夫斯甲亢治疗的长期结局。
Thyroid. 2019 Nov;29(11):1545-1557. doi: 10.1089/thy.2019.0085.
8
Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.格雷夫斯甲亢:抗甲状腺药物、手术或放射性碘治疗——一项前瞻性随机研究。甲状腺研究小组
J Clin Endocrinol Metab. 1996 Aug;81(8):2986-93. doi: 10.1210/jcem.81.8.8768863.
9
Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.Graves 病患者的术后结果:全国住院患者样本数据库的结果。
Thyroid. 2017 Jun;27(6):825-831. doi: 10.1089/thy.2016.0500. Epub 2017 May 22.
10
Management of Graves Disease: A Review.格雷夫斯病的治疗:综述。
JAMA. 2015 Dec 15;314(23):2544-54. doi: 10.1001/jama.2015.16535.

引用本文的文献

1
Comparison of mortality and cardiovascular morbidity following treatment for hyperthyroidism: A systematic review and bayesian network meta-analysis.甲状腺功能亢进症治疗后死亡率和心血管疾病发病率的比较:一项系统评价和贝叶斯网络荟萃分析。
Endocrine. 2025 Jul 8. doi: 10.1007/s12020-025-04342-4.
2
Prevalence and Risk Factors of Heart Failure in Patients Diagnosed with Hyperthyroidism: A Systematic Review and Meta-analysis.甲状腺功能亢进症患者心力衰竭的患病率及危险因素:一项系统评价和Meta分析
touchREV Endocrinol. 2024 Oct;20(2):91-99. doi: 10.17925/EE.2024.20.2.12. Epub 2024 Jul 22.
3
MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or Thyroidectomy.
药物、放射性碘或甲状腺切除术治疗的心肌梗死、卒中和心力衰竭与甲状腺功能亢进症
JAMA Netw Open. 2024 Mar 4;7(3):e240904. doi: 10.1001/jamanetworkopen.2024.0904.
4
Graves' disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study.格雷夫斯病、其治疗方法与心房颤动风险:一项基于韩国人群的研究。
Front Endocrinol (Lausanne). 2022 Nov 1;13:1032764. doi: 10.3389/fendo.2022.1032764. eCollection 2022.
5
Radiofrequency ablation as a novel modality in the USA for treating toxic thyroid nodules: case series and literature review.射频消融术作为美国治疗毒性甲状腺结节的一种新方法:病例系列及文献综述
Gland Surg. 2022 Sep;11(9):1574-1583. doi: 10.21037/gs-22-35.
6
Attaining biochemical euthyroidism early after total thyroidectomy in Graves' disease may lower long-term morbidity risk.Graves 病患者行甲状腺全切除术早期达到生化甲状腺功能正常可能降低长期发病风险。
BJS Open. 2022 Jul 7;6(4). doi: 10.1093/bjsopen/zrac079.